ScholarIQanswers from OpenAlex

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

PaperCitations, authors & open-access status

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer have?

ScholarIQcitation count

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer has 472 citations in the OpenAlex counts ScholarIQ stores.

When was A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer published?

ScholarIQyear

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer has 2014 year in the ScholarIQ index.

What is the open-access status of A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer?

ScholarIQoa status

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer has bronze oa status in the ScholarIQ index.

What is the DOI of A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer?

ScholarIQdoi

The DOI for A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer is on the source record.

What is the PMID of A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer?

ScholarIQpmid

The PMID for A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer is on the source record.

What is the OpenAlex record for A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer?

ScholarIQopenalex

The OpenAlex for A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial